Chinese drug maker investing $42M in Nabsys, report says

A REPORT from China Money Network said that a Chinese drug manufacturer is investing $42 million in Nabsys.
A REPORT from China Money Network said that a Chinese drug manufacturer is investing $42 million in Nabsys.
PROVIDENCE – A Chinese drug manufacturer is investing $42 million in Nabsys, which recently completed a financial restructuring that allowed it to reopen in March after being out of business for nearly seven months. The investment was reported Friday by China Money Network, a media company that follows news about the alternative investment industry in…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -